News

TX-RAD is a type 1 regulatory T cell based immunotherapy used for the treatment of joint inflammatory diseases like rheumatoid arthritis. The study RATS1 (Rheumatoid arthritis And Tr1

The single-use cell cassettes are the central component used in Aastrom’s proprietary culturing process at its cell manufacturing facility in Ann Arbor, Michigan. In addition, Aastrom’s ixmyelocel-T has

The tie up aims to identify new chemical compounds that slow down the activity of novel protein target, proposed by IPD. The results of the computational analysis will

Prior to the NOA, BioLineRx has received approval for BL-1020 drug in Australia, Korea and China. In pre-clinical and clinical trials, BL-1020 was effective at treating schizophrenia symptoms

Capugel is a provider of hard capsules and an innovator in drug delivery systems for the pharmaceutical, OTC and health and nutrition industries. Folllowing the transaction, all Pfizer

The decision is followed by renewal inspection by a team from the regulatory agency. Suven Life Sciences is an India-based contract research and manufacturing services (CRAMS) provider, which

The active categories which the new patent covers include opiate and opiate derivatives such as buprenorphine and naloxone, anti-emetics such as ondansetron and granisetron hydrochloride, analgesics such as

The study enrolled healthy male and female volunteers, who received a single dose of Bendavia administered as an intravenous infusion over an extended period. Safety trial from the

MEDai, a subsidiary of Elsevier, offers solutions for the improvement of healthcare delivery. AtlantiCare will use MEDai’s Risk Navigator solutions in conjunction with its patient-centered medical home model